Equities research analysts expect RTI Surgical Inc (NASDAQ:RTIX) to report sales of $70.16 million for the current quarter, Zacks reports. Two analysts have issued estimates for RTI Surgical’s earnings, with estimates ranging from $69.49 million to $70.82 million. RTI Surgical posted sales of $71.35 million during the same quarter last year, which suggests a negative year-over-year growth rate of 1.7%. The company is scheduled to issue its next earnings report on Thursday, February 22nd.

On average, analysts expect that RTI Surgical will report full year sales of $70.16 million for the current fiscal year, with estimates ranging from $278.40 million to $279.56 million. For the next year, analysts forecast that the company will post sales of $282.10 million per share, with estimates ranging from $281.94 million to $282.26 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow RTI Surgical.

RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.01. The business had revenue of $66.69 million during the quarter, compared to analysts’ expectations of $65.63 million. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The firm’s quarterly revenue was up .2% on a year-over-year basis.

Several research analysts have recently issued reports on RTIX shares. Zacks Investment Research raised RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, October 13th. BidaskClub cut RTI Surgical from a “hold” rating to a “sell” rating in a research report on Tuesday, December 5th.

RTI Surgical (RTIX) opened at $4.40 on Tuesday. The stock has a market capitalization of $261.84, a PE ratio of -62.86, a PEG ratio of 1.96 and a beta of 1.76. RTI Surgical has a 1 year low of $3.01 and a 1 year high of $6.00. The company has a current ratio of 3.34, a quick ratio of 1.21 and a debt-to-equity ratio of 0.25.

Large investors have recently added to or reduced their stakes in the company. AJO LP acquired a new position in shares of RTI Surgical during the 2nd quarter worth about $2,597,000. Strs Ohio boosted its position in shares of RTI Surgical by 19.5% during the 3rd quarter. Strs Ohio now owns 142,300 shares of the medical equipment provider’s stock worth $647,000 after acquiring an additional 23,200 shares in the last quarter. Menta Capital LLC boosted its position in shares of RTI Surgical by 51.5% during the 2nd quarter. Menta Capital LLC now owns 160,958 shares of the medical equipment provider’s stock worth $942,000 after acquiring an additional 54,685 shares in the last quarter. Allianz Asset Management GmbH boosted its position in shares of RTI Surgical by 73.5% during the 3rd quarter. Allianz Asset Management GmbH now owns 235,560 shares of the medical equipment provider’s stock worth $1,072,000 after acquiring an additional 99,780 shares in the last quarter. Finally, Macquarie Group Ltd. acquired a new stake in shares of RTI Surgical in the 3rd quarter valued at about $280,000. 69.90% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This news story was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://theolympiareport.com/2018/01/16/70-16-million-in-sales-expected-for-rti-surgical-inc-rtix-this-quarter.html.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.